{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:59:26Z","timestamp":1790913566789,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":218,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972169"],"award-info":[{"award-number":["81972169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2020CXJQ02"],"award-info":[{"award-number":["2020CXJQ02"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101362","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:47:56Z","timestamp":1786427276000},"page":"101362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of preoperative plasma cytokines for the diagnosis and prognosis of malignant lung nodules"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6529-288X","authenticated-orcid":false,"given":"Lei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caicun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctarc.2026.101362_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101362_bib0002","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101362_bib0003","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.chest.2023.11.042","article-title":"Recurrence-free survival in patients with surgically resected non-small cell lung cancer: a systematic literature review and meta-analysis","volume":"165","author":"Rajaram","year":"2024","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101362_bib0004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/14789450.2021.1892491","article-title":"Studies in lung cancer cytokine proteomics: a review","volume":"18","author":"Abolfathi","year":"2021","journal-title":"Expert. Rev. Proteom"},{"issue":"29","key":"10.1016\/j.ctarc.2026.101362_bib0005","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1038\/s41388-019-0840-4","article-title":"Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-kappaB-CCL2 signaling in lung cancer","volume":"38","author":"Zhou","year":"2019","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.ctarc.2026.101362_bib0006","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1177\/1535370216644530","article-title":"Benzopyrene promotes lung cancer A549 cell migration and invasion through up-regulating cytokine IL8 and chemokines CCL2 and CCL3 expression","volume":"241","author":"Zhang","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101362_bib0007","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/1759-7714.12643","article-title":"High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma","volume":"9","author":"Li","year":"2018","journal-title":"Thorac Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101362_bib0008","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1038\/s41598-019-42345-0","article-title":"Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data","volume":"9","author":"Dong","year":"2019","journal-title":"Sci. Rep"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101362_bib0009","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1158\/0008-5472.CAN-09-2533","article-title":"Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib","volume":"70","author":"Nikolinakos","year":"2010","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101362_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124283","article-title":"High EMT signature score of invasive non-small cell lung cancer (NSCLC) cells correlates with NFkappaB driven colony-stimulating factor 2 (CSF2\/GM-CSF) secretion by neighboring stromal fibroblasts","volume":"10","author":"Rudisch","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101362_bib0011","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/annonc\/mdu549","article-title":"Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis","volume":"26","author":"Barrera","year":"2015","journal-title":"Ann. Oncol"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101362_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099568","article-title":"Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages","volume":"9","author":"Watari","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101362_bib0013","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00262-018-2196-y","article-title":"Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer","volume":"67","author":"Barrera","year":"2018","journal-title":"Cancer Immunol. Immunother"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101362_bib0014","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s002620000150","article-title":"Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival","volume":"49","author":"Orditura","year":"2000","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.ctarc.2026.101362_bib0015","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.3389\/fimmu.2019.02638","article-title":"Activation of the IL-4\/STAT6 signaling pathway promotes lung cancer progression by increasing M2 myeloid cells","volume":"10","author":"Fu","year":"2019","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101362_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181125","article-title":"High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer","volume":"12","author":"Silva","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101362_bib0017","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4049\/jimmunol.1701069","article-title":"Myeloid-derived suppressor cells impair B cell responses in lung cancer through IL-7 and STAT5","volume":"201","author":"Wang","year":"2018","journal-title":"J. Immunol"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101362_bib0018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.2009.22.4279","article-title":"Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and\/or chemotherapy in patients with non-small-cell lung cancer","volume":"28","author":"Hanrahan","year":"2010","journal-title":"J. Clin. Oncol"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101362_bib0019","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.lungcan.2009.12.012","article-title":"CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer","volume":"69","author":"Miotto","year":"2010","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101362_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.65","article-title":"Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease","volume":"5","author":"Eide","year":"2016","journal-title":"Clin. Transl. Immunol"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101362_bib0021","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/carcin\/bgs384","article-title":"Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor","volume":"34","author":"Li","year":"2013","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101362_bib0022","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s12032-010-9645-6","article-title":"Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival","volume":"28","author":"Su","year":"2011","journal-title":"Med. Oncol"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101362_bib0023","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00262-011-1059-6","article-title":"Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin","volume":"60","author":"Li","year":"2011","journal-title":"Cancer Immunol. Immunother"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101362_bib0024","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/JTO.0000000000000606","article-title":"Folate receptor-positive circulating tumor cell detected by LT-PCR-based method as a diagnostic biomarker for non-small-cell lung cancer","volume":"10","author":"Chen","year":"2015","journal-title":"J. Thorac. Oncol"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101362_bib0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1055-9965.EPI-18-0598","article-title":"Relationship between circulating inflammation proteins and lung cancer diagnosis in the national lung screening trial","volume":"28","author":"Brown","year":"2019","journal-title":"Cancer Epidemiol Biomark. Prev"},{"issue":"25","key":"10.1016\/j.ctarc.2026.101362_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202001695","article-title":"Overcoming obstacles in pathological diagnosis of pulmonary nodules through circulating tumor cell enrichment","volume":"16","author":"Yin","year":"2020","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101362_bib0027","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2021.24287","article-title":"Evaluating the patient with a pulmonary nodule: a review","volume":"327","author":"Mazzone","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101362_bib0028","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.chest.2023.05.025","article-title":"Update on biomarkers for the stratification of indeterminate pulmonary nodules","volume":"164","author":"Paez","year":"2023","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101362_bib0029","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.chest.2018.02.012","article-title":"Assessment of plasma proteomics biomarker's ability to distinguish benign from malignant lung nodules: results of the PANOPTIC (Pulmonary nodule plasma proteomic classifier) trial","volume":"154","author":"Silvestri","year":"2018","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101362_bib0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chest.2020.10.069","article-title":"Assessment of integrated classifier's ability to distinguish benign from malignant lung nodules: extended analyses and 2-year follow-up results of the PANOPTIC (Pulmonary nodule plasma proteomic classifier) trial","volume":"159","author":"Tanner","year":"2021","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101362_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287409","article-title":"Assessing a biomarker's ability to reduce invasive procedures in patients with benign lung nodules: results from the ORACLE study","volume":"18","author":"Pritchett","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ctarc.2026.101362_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155759","article-title":"Cytokines screening identifies MIG (CXCL9) for postoperative recurrence prediction in operated non-small cell lung cancer patients","volume":"149","author":"Zhang","year":"2022","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101362_bib0033","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","article-title":"Role of thymic stromal lymphopoietin in allergy and beyond","volume":"23","author":"Ebina-Shibuya","year":"2023","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.ctarc.2026.101362_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1627235","article-title":"TSLP: contrasting roles in cancer","volume":"16","author":"Poto","year":"2025","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101362_bib0035","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3390\/cancers14092173","article-title":"Thymic stromal lymphopoietin induction suppresses lung cancer development","volume":"14","author":"Guennoun","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101362_bib0036","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1419115","article-title":"Tumor-derived thymic stromal lymphopoietin enhances lung metastasis through an alveolar macrophage-dependent mechanism","volume":"7","author":"Burkard-Mandel","year":"2018","journal-title":"Oncoimmunology"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600273X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600273X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:51:45Z","timestamp":1790913105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422600273X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":36,"alternative-id":["S246829422600273X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101362","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of preoperative plasma cytokines for the diagnosis and prognosis of malignant lung nodules","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101362"}}